“Adalimumab and Etanercept in the Treatment of Rheumatoid Arthritis and Spondyloarthropathies: Budget Impact Model of Dose Reduction ”. Journal of Pharmacy and Nutrition Sciences 4, no. 3 (June 5, 2014): 170–176. Accessed February 17, 2026. https://setpublisher.com/index.php/jpans/article/view/1689.